|
ZC3HAV1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.641100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.680600E-03 |
| Normal-vs-Stage2 |
3.072500E-02 |
| Normal-vs-Stage3 |
3.202200E-03 |
| Normal-vs-Stage4 |
2.831700E-02 |
| Stage1-vs-Stage2 |
9.159400E-01 |
| Stage1-vs-Stage3 |
6.816600E-01 |
| Stage1-vs-Stage4 |
8.002400E-01 |
| Stage2-vs-Stage3 |
6.360800E-01 |
| Stage2-vs-Stage4 |
7.208400E-01 |
| Stage3-vs-Stage4 |
9.914000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.661700E-03 |
| Normal-vs-AfricanAmerican |
3.841300E-03 |
| Normal-vs-Asian |
5.506300E-02 |
| Caucasian-vs-AfricanAmerican |
6.880200E-01 |
| Caucasian-vs-Asian |
6.616200E-01 |
| AfricanAmerican-vs-Asian |
7.504400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.87989999999428E-05 |
| Normal-vs-Female |
3.744600E-01 |
| Male-vs-Female |
2.636100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.805800E-02 |
| Normal-vs-Extreme_Weight |
1.580530E-04 |
| Normal-vs-Obese |
4.357800E-02 |
| Normal-vs-Extreme_Obese |
9.379300E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.255170E-01 |
| Normal_Weight-vs-Obese |
9.244800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.116200E-02 |
| Extreme_Weight-vs-Obese |
5.618200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.850800E-01 |
| Obese-vs-Extreme_Obese |
1.320090E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.498060E-02 |
| Normal-vs-Age(41-60Yrs) |
4.675900E-02 |
| Normal-vs-Age(61-80Yrs) |
8.963600E-04 |
| Normal-vs-Age(81-100Yrs) |
7.137600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.625400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.150600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.698400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.793800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.584440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.105000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.588000E-04 |
| Normal-VS-Type2 PRCC |
2.941100E-03 |
| Normal-VS-KIRP CIMP |
6.310400E-01 |
| Normal-VS-Unclassified PRCC |
2.195400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.823400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.398300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.524200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.141700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.908220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.195400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.92720000022651E-07 |
| Normal-vs-N1 |
5.807500E-02 |
| Normal-vs-N2 |
3.889000E-01 |
| N0-vs-N1 |
1.046450E-02 |
| N0-vs-N2 |
1.693190E-01 |
| N1-vs-N2 |
9.453600E-01 |
|
|
